Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

Pentagastrin

Name
Pentagastrin
Molecular structural formula
Purity
≥95%
Formula
C37H50N7O9S1
MW
768.79
Target
Cholecystokinin Receptor
Sequence
Boc-beta-Ala-Trp-Met-Asp-Phe-NH2
Sequence Shortening
Boc-beta-AWMDF-NH2
InChIKey
NEYNJQRKHLUJRU-DZUOILHNSA-N
Solubility in DMSO
≥ 34 mg/mL
Solubility in water
< 0.1 mg/mL
References
[1]. Smith AJ, et al. Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation. Eur J Pharmacol. 1994 Apr 15;267(2):215-23. [2]. Tanaka S, et al. Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion. Gut. 1998 Sep;43(3):334-41.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Pentagastrin (ICI-50123) is a potent, selective Cholecystokinin B (CCKB) receptor antagonists with IC50 values of 11 nM and 1100 nM for CCKB and CCKA, respectively. Pentagastrin enhances gastric mucosal defense mechanisms against acid and protects the gastric mucosa from experimental injury.